Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 1,149.00
+11.00 (0.97%)
Jul 21, 2026, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 80.95 billion as of July 21, 2026. Its market cap has decreased by -65.17% in one year.
Market Cap
80.95B
Enterprise Value
136.37B
Revenue
43.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,149.00
ChartMarket Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 80.95B, a decrease of -65.87%. That is a compound annual growth rate of -8.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 80.95B | -18.19% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoImmuneTech | 134.86B |
| Macrogen | 127.17B |
| Genexine | 106.88B |
| Vaxcell-Bio Therapeutics | 96.40B |
| MedPacto | 92.37B |
| iNtRON Biotechnology | 79.35B |
| ENCell | 72.13B |
| CG Invites | 67.97B |